Fmoc-Trt-L-Lysine is a protected derivative of the amino acid L-lysine, featuring an N-terminal 9-fluorenylmethoxycarbonyl (Fmoc) protecting group and a side-chain ε-amino group protected by a trityl (Trt) group. This specific protection scheme is critical for its primary application. This compound is a fundamental building block in solid-phase peptide synthesis (SPPS) using the Fmoc strategy. The Fmoc group is base-labile and can be removed under mild conditions (e.g., with piperidine), while the acid-labile Trt group protects the lysine side chain during chain elongation. This orthogonal protection allows for the selective incorporation of lysine residues and the subsequent on-resin or post-synthesis deprotection of the side chain for further functionalization or to restore its cationic nature, which is essential for the biological activity of many peptides. As a high-purity, specialty amino acid derivative, it is a staple reagent in pharmaceutical research, biochemistry, and biotechnology for the production of custom peptides, peptide hormones, and investigational drug candidates. Its use is confined almost exclusively to controlled laboratory synthesis environments.